Viewing Study NCT00539669


Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2026-01-01 @ 9:57 AM
Study NCT ID: NCT00539669
Status: COMPLETED
Last Update Posted: 2007-10-04
First Post: 2007-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module